Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

The effect of liver transplantation for primary sclerosing cholangitis on disease activity in patients with inflammatory bowel disease.

Mosli M, Croome K, Qumosani K, Al-Judaibi B, Beaton M, Marotta P, Chandok N.

Gastroenterol Hepatol (N Y). 2013 Jul;9(7):434-41.

2.

The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis.

Joshi D, Bjarnason I, Belgaumkar A, O'Grady J, Suddle A, Heneghan MA, Aluvihare V, Rela M, Heaton N, Agarwal K.

Liver Int. 2013 Jan;33(1):53-61. doi: 10.1111/j.1478-3231.2011.02677.x. Epub 2011 Nov 22.

PMID:
22103794
3.

Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.

Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer A, Buckels JA, McMaster P, Neuberger J, Mirza DF.

Transplantation. 2003 Jun 27;75(12):1983-8.

PMID:
12829898
4.

Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series.

Altwegg R, Combes R, Laharie D, De Ledinghen V, Radenne S, Conti F, Chazouilleres O, Duvoux C, Dumortier J, Leroy V, Treton X, Durand F, Dharancy S, Nachury M, Goutorbe F, Lamblin G, Boivineau L, Peyrin-Biroulet L, Pageaux GP.

Dig Liver Dis. 2018 Jul;50(7):668-674. doi: 10.1016/j.dld.2018.02.014. Epub 2018 Mar 13.

PMID:
29655972
5.

Clinical management of inflammatory bowel disease in the organ recipient.

Indriolo A, Ravelli P.

World J Gastroenterol. 2014 Apr 7;20(13):3525-33. doi: 10.3748/wjg.v20.i13.3525. Review.

6.

Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.

Mouchli MA, Singh S, Boardman L, Bruining DH, Lightner AL, Rosen CB, Heimbach JK, Hasan B, Poterucha JJ, Watt KD, Kane SV, Raffals LE, Loftus EV Jr.

Inflamm Bowel Dis. 2018 Apr 23;24(5):1074-1081. doi: 10.1093/ibd/izx096.

7.

Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.

Singh S, Loftus EV Jr, Talwalkar JA.

Am J Gastroenterol. 2013 Sep;108(9):1417-25. doi: 10.1038/ajg.2013.163. Epub 2013 Jul 30. Review.

PMID:
23896954
8.

Pediatric liver transplantation for primary sclerosing cholangitis.

Miloh T, Anand R, Yin W, Vos M, Kerkar N, Alonso E; Studies of Pediatric Liver Transplantation Research Group.

Liver Transpl. 2011 Aug;17(8):925-33. doi: 10.1002/lt.22320.

9.

Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis.

Hildebrand T, Pannicke N, Dechene A, Gotthardt DN, Kirchner G, Reiter FP, Sterneck M, Herzer K, Lenzen H, Rupp C, Barg-Hock H, de Leuw P, Teufel A, Zimmer V, Lammert F, Sarrazin C, Spengler U, Rust C, Manns MP, Strassburg CP, Schramm C, Weismüller TJ; German PSC Study Group.

Liver Transpl. 2016 Jan;22(1):42-52. doi: 10.1002/lt.24350.

10.

Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis.

Hanouneh IA, Macaron C, Lopez R, Zein NN, Lashner BA.

Inflamm Bowel Dis. 2012 Feb;18(2):269-74. doi: 10.1002/ibd.21692. Epub 2011 Mar 18.

PMID:
21425212
11.

Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report.

Åberg F, Abdulle A, Mäkelä A, Nissinen M.

Transplant Proc. 2015 Nov;47(9):2775-7. doi: 10.1016/j.transproceed.2015.09.043.

PMID:
26680092
12.

Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.

Fousekis FS, Theopistos VI, Mitselos IV, Skamnelos A, Kavvadias A, Katsanos KH, Christodoulou DK.

J Clin Med Res. 2019 Feb;11(2):81-88. doi: 10.14740/jocmr3680. Epub 2019 Jan 5. Review.

13.

Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.

Rao BB, Lashner B, Kowdley KV.

Inflamm Bowel Dis. 2018 Jan 18;24(2):269-276. doi: 10.1093/ibd/izx056. Review. Erratum in: Inflamm Bowel Dis. 2018 Nov 29;24(12):2656.

PMID:
29361103
14.

Inflammatory bowel disease in liver transplanted patients.

Filipec Kanizaj T, Mijic M.

World J Gastroenterol. 2017 May 14;23(18):3214-3227. doi: 10.3748/wjg.v23.i18.3214. Review.

15.

Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis.

Singh S, Edakkanambeth Varayil J, Loftus EV Jr, Talwalkar JA.

Liver Transpl. 2013 Dec;19(12):1361-9. Review.

16.

Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.

Jørgensen KK, Lindström L, Cvancarova M, Karlsen TH, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM.

Clin Gastroenterol Hepatol. 2013 May;11(5):517-23. doi: 10.1016/j.cgh.2012.12.027. Epub 2013 Jan 16.

PMID:
23333218
17.

Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis.

van de Vrie W, de Man RA, van Buuren HR, Schouten WR, Tilanus HW, Metselaar HJ.

Eur J Gastroenterol Hepatol. 2003 Jun;15(6):657-63.

PMID:
12840678
18.

Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.

Franceschet I, Cazzagon N, Del Ross T, D'Incà R, Buja A, Floreani A.

Eur J Gastroenterol Hepatol. 2016 May;28(5):508-13. doi: 10.1097/MEG.0000000000000596.

PMID:
26872110
19.

Primary Sclerosing Cholangitis with Inflammatory Bowel Disease in Korean Children.

Yoon J, Oh SH, Kim HJ, Park SH, Ye BD, Yang SK, Kim KM.

Pediatr Gastroenterol Hepatol Nutr. 2015 Dec;18(4):268-75. doi: 10.5223/pghn.2015.18.4.268. Epub 2015 Dec 23.

20.

Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study.

Khettry U, Keaveny A, Goldar-Najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, Jenkins RL, Gordon FD.

Hum Pathol. 2003 Nov;34(11):1127-36.

PMID:
14652814

Supplemental Content

Support Center